clinical-stage vaccine company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $130,000 | |
| 2026 | NOVAVAX, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $140,000 | |
| 2025 | NOVAVAX, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $110,000 | |
| 2025 | NOVAVAX, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $230,000 | |
| 2025 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $190,000 | |
| 2025 | NOVAVAX, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $170,000 | |
| 2024 | NOVAVAX, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $100,000 | |
| 2024 | NOVAVAX, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $90,000 | |
| 2024 | NOVAVAX, INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $90,000 | |
| 2024 | NOVAVAX, INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $130,000 |
| Client | Filings | Total Income |
|---|---|---|
| NOVAVAX, INC | 42 | — |
| Name | Disclosed Prior Position |
|---|---|
| JAMES CAMPOLONGO | |
| KELLY CAPPIO | |
| DANIELLE FREDERICKS | |
| BRIAN ROSEN |